Unternehmens-Profil
Pfizer Inc. is a research-based global biopharmaceutical company founded in 1849 and headquartered in New York. It focuses on the discovery, development, manufacture, marketing, sales, and distribution of biopharmaceutical products worldwide, targeting developed and emerging markets to advance wellness, prevention, treatments, and cures for the most feared diseases. Operating in the health technology sector, specifically pharmaceuticals: major, Pfizer Inc. addresses critical areas such as oncology, rare diseases, internal medicine, inflammation and immunology, vaccines, anti-infectives, gene therapy, medicinal sciences, and precision medicine. Notable advancements include acquisitions like Global Blood Therapeutics in 2023 to bolster its biopharmaceutical portfolio, alongside recent clinical trial successes in prostate cancer, lung cancer, and bladder cancer therapies. With approximately 81,000 employees, Pfizer Inc. generates substantial revenue, reported at $63.63 billion for the fiscal year, and maintains a significant presence in the global market through innovative pipelines and partnerships.
Bewertungs-Kennzahlen
Allgemeine Finanzkennzahlen
Chart · 90 Tage
Letzter Kurs: 26,485 USD· Stand 07.05.2026
News · Pfizer Inc.
- Obvious Dividend Traps: 4 We Exited And 1 We Wouldn't Touch With A 10-Foot Pole
- History Suggests These 3 Stocks Are Due for a Major Rebound
- 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash
- Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC
- Pfizer CEO on AI-designed molecule, and race to use new tech